Phase IIIb study of durvalumab plus platinumeetoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Safety results

被引：3

作者：

Casado, M. D. Isla ^{[1
]}

Arriola, E. ^{[2
]}

Garcia-Campelo, M. R. ^{[3
]}

Tain, P. Diz ^{[4
]}

Blanco, C. Marti ^{[5
]}

Piqueras, M. M. Lopez-Brea ^{[6
]}

Vega, A. L. Moreno ^{[7
]}

Mateos, L. A. Leon ^{[8
]}

Rodriguez, J. M. Oramas ^{[9
]}

Calderon, V. Gutierrez ^{[10
]}

Majem, M. ^{[11
]}

Hernandez, A. Sanchez ^{[12
]}

Aguado, C. ^{[13
]}

Cabellos, R. Alvarez ^{[14
]}

Ciriquian, J. L. Marti ^{[15
]}

Paul, A. Moreno ^{[16
]}

Perez, J. L. Firvida ^{[17
]}

Mellen, A. Callejo ^{[18
]}

Baez, L. ^{[18
]}

Paz-Ares, L. ^{[19
]}

机构：

[1] Hosp Clin Univ Lozano Blesa, Med Oncol Dept, Zaragoza, Spain

[2] Hosp Mar, Dept Med Oncol, Parc Salut Mar, Barcelona, Spain

[3] CHUAC Complexo Hosp Univ A Coruna, Dept Med Oncol, La Coruna, Spain

[4] Hosp Leon, Complejo Asistencial Univ Leon, Dept Med Oncol, Leon, Spain

[5] Hosp Univ Sant Joan Reus, Med Oncol, Reus, Spain

[6] HUMV Hosp Univ Marques Valdecilla, Med oncol, Santander, Spain

[7] Hosp Univ Virgen Rocio, Dept Med Oncol, Seville, Spain

[8] CHUS Complejo Hosp Univ Santiago de Compostela, Med Oncol, Santiago De Compostela, Spain

[9] Hosp Univ Canarias, Med Oncol, Santa Cruz De Tenerife, Canary Islands, Spain

[10] Hosp Reg Univ Malaga Carlos Haya, Med oncol, Malaga, Spain

[11] Hosp Santa Creu & Sant Pau, Med Oncol, Barcelona, Spain

[12] Consorcio Hosp Prov Castellon, Dept Med Oncol, Castellon De La Plana, Spain

[13] Hosp Clin Univ San Carlos, Med Oncol Dept, Madrid, Spain

[14] Hosp Virgen Salud, Oncol Med, Toledo, Spain

[15] Hosp Gen Univ Alicante, Med Oncol, Alicante, Spain

[16] Hosp Galdakao Usansolo, Med Oncol, Galdakao, Spain

[17] Ctr Med El Carmen, Med Oncol, Orense, Spain

[18] AstraZeneca Farmaceut Spain S A, Med Dept, Madrid, Spain

[19] Hosp Univ 12 Octubre, Med Oncol Dept, Edificio Matern 2a planta, Madrid, Spain

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.1224

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1993P

引用

页码：S1063 / S1063

页数：1

共 50 条

[1] Phase IIIb study of durvalumab plus platinumeetoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Treatment patterns of chemotherapy combination phase with durvalumab
Isla, D.
Arriola, E.
Garcia Campelo, M. R.
Marti, C.
Diz Tain, P.
Moreno Vega, A. L.
Piqueras, M. L-B.
Leon, L.
Gutierrez Calderon, V.
Oramas Rodriguez, J. M.
Majem, M.
Sanchez-Hernandez, A.
Aguado de la Rosa, C.
Alvarez Cabellos, R.
Marti-Ciriquian, J. L.
Moreno Paul, A.
Gonzalez Cordero, M.
Callejo Mellen, A.
Baez, L.
Zugazagoitia, J.
ANNALS OF ONCOLOGY, 2022, 33 : S98 - S99
[2] Phase IIIb study of durvalumab plus platinum-etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Preliminary efficacy results
Isla, D.
Arriola, E.
Garcia Campelo, M. R.
Diz Tain, P.
Marti Blanco, C.
Lopez-Brea Piqueras, M. M.
Moreno Vega, A. L.
Leon Mateos, L. A.
Oramas Rodriguez, J. M.
Gutierrez Calderon, V.
Majem Tarruella, M.
Sanchez Hernandez, A.
Aguado de la Rosa, C.
Alvarez Cabellos, R.
Marti Ciriquian, J. L.
Paul, A. Moreno
Firvida Perez, J. L.
Callejo Mellen, A.
Baez, L.
Paz-Ares, L.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S1247 - S1248
[3] Durvalumab plus platinum-etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A Spanish phase IIIb single arm, real-world study
Paz-Ares, L.
Arriola, E.
Campelo, M. R. Garcia
Tain, M. P. Diz
Blanco, M. C. Marti
Vega, A. L. Moreno
Leon-Mateos, L.
Calderon, V. Gutierrez
Hernandez, A. Sanchez
Rodriguez, J. M. Oramas
Majem, M.
De la Rosa, C. Aguado
Cabellos, R. Alvarez
Ciriquian, J. L. Marti
Amezcua, V.
Perez, J. L. Firvida
Mellen, A. Callejo
Baez, L.
Isla, D.
ANNALS OF ONCOLOGY, 2021, 32 : S1171 - S1172
[4] HOSPITALIZATIONS IN PATIENTS RECEIVING DURVALUMAB PLUS PLATINUM-ETOPOSIDE IN FIRST-LINE TREATMENT OF EXTENSIVE-STAGE SMALL-CELL LUNG CANCER: EXPLORATORY ANALYSIS FROM THE PHASE IIIB CANTABRICO STUDY
Isla, D.
Arriola, E.
Garcia-Campelo, R.
Marti, C.
Diz, P.
Lopez-Brea, M.
Moreno, A. L.
Leon-Mateos, L.
Oramas, J.
Gutierrez, V
Majem, M.
Sanchez-Hernandez, A.
Aguado de la Rosa, C.
Alvarez, R.
Massuti, B.
Moreno, A.
Firvida, J. L.
Dominguez, M.
Sanchez, C.
Martinez, A.
Baret, M.
Paz-Ares, L.
VALUE IN HEALTH, 2024, 27 (12) : S91 - S91
[5] Cost-Effectiveness Analysis of Durvalumab Plus Chemotherapy in the First-Line Treatment of Extensive-Stage Small Cell Lung Cancer
Ding, Dong
Hu, Huabin
Li, Shuosha
Zhu, Youwen
Shi, Yin
Liao, Mengting
Liu, Jin
Tian, Xu
Liu, Aiting
Huang, Jin
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (10): : 1141 - +
[6] Efficacy and safety analysis of anlotinib and durvalumab plus chemotherapy in first-line therapy extensive-stage small cell lung cancer (SCLC)
Chen, L.
Zhao, Y.
Wu, H.
Hu, X.
Wu, H.
ANNALS OF ONCOLOGY, 2022, 33 : S1580 - S1580
[7] Phase II study of anlotinib plus durvalumab and chemotherapy as first-line treatment in extensive-stage small cell lung cancer (ES-SCLC): Efficacy and safety analysis.
Chen, Lijuan
Zhao, Yanqiu
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[8] Phase I study of paclitaxel and topotecan for the first-line treatment of extensive-stage small cell lung cancer
West, W
Birch, R
Schnell, F
Hainsworth, J
Tongol, J
Campos, L
ONCOLOGIST, 2003, 8 (01): : 76 - 82
[9] First-line atezolizumab/durvalumab plus platinum–etoposide combined with radiotherapy in extensive-stage small-cell lung cancer
Lijuan Li
Dan Yang
Yanmei Min
Anyan Liao
Jing Zhao
Leilei Jiang
Xin Dong
Wei Deng
Huiming Yu
Rong Yu
Jun Zhao
Anhui Shi
BMC Cancer, 23
[10] Tarlatamab Plus Durvalumab as First-Line Maintenance in Extensive-Stage Small Cell Lung Cancer: DeLLphi-305 Phase 3 Trial
Perol, M.
Ahn, M. -J.
Cheng, Y.
Clarke, J.
Dingemans, A. -M.
Gay, C.
Navarro, A.
Schuler, M.
Yoshida, T.
Martinez, P.
Anderson, E. S.
Sands, J.
JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S206 - S207

← 1 2 3 4 5 →